INVESTIGATE-I (INVasive Evaluation before Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): study protocol for a mixed methods study to assess the feasibility of a future randomised controlled trial of the clinical utility of invasive urodynamic testing
Background: Urinary incontinence is an important health problem to the individual sufferer and to health services. Stress and stress predominant mixed urinary incontinence are increasingly managed by surgery due to advances in surgical techniques. Despite the lack of evidence for its clinical utilit...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Urinary incontinence is an important health problem to the individual sufferer and to health services.
Stress and stress predominant mixed urinary incontinence are increasingly managed by surgery due to advances in
surgical techniques. Despite the lack of evidence for its clinical utility, most clinicians undertake invasive urodynamic
testing (IUT) to confirm a functional diagnosis of urodynamic stress incontinence before offering surgery for this
condition. IUT is expensive, embarrassing and uncomfortable for women and carries a small risk. Recent systematic
reviews have confirmed the lack of high quality evidence of effectiveness.
The aim of this pilot study is to test the feasibility of a future definitive randomised control trial that would address
whether IUT alters treatment decisions and treatment outcome in these women and would test its clinical and
cost effectiveness.
Methods/design: This is a mixed methods pragmatic multicentre feasibility pilot study with four components:-
(a) A multicentre, external pilot randomised trial comparing basic clinical assessment with non-invasive tests and
IUT. The outcome measures are rates of recruitment, randomisation and data completion. Data will be used to
estimate sample size necessary for the definitive trial.
(b) Qualitative interviews of a purposively sampled sub-set of women eligible for the pilot trial will explore
willingness to participate, be randomised and their overall trial experience.
(c) A national survey of clinicians to determine their views of IUT in this context, the main outcome being their
willingness to randomise patients into the definitive trial.
(d) Qualitative interviews of a purposively sampled group of these clinicians will explore whether and how they
use IUT to inform their decisions.
Discussion: The pilot trial will provide evidence of feasibility and acceptability and therefore inform the decision
whether to proceed to the definitive trial. Results will inform the design and conduct of the definitive trial and
ensure its effectiveness in achieving its research aim. |
---|---|
DOI: | 10.1186/1745-6215-12-169 |